Abstract:Nearly 250,000 women die each year from cardiovascular disease, making it the leading cause of death in women. The initial clinical manifestation of coronary artery disease (CAD) in women is usually 10 years later than in men on average, with the first myocardial infarction presenting 20 years later. At any age the prevalence of CAD is lower in women, but with advancing age, this gender differential diminishes. The fact that CAD prevalence is lower in women has led to the false presumption that women are protected from cardiovascular diseases. Since women live 8 to 10 years longer than men, the absolute number of deaths from cardiovascular disease (CVD) exceeds that of men. Although there has been a decline in the overall number of cardiovascular deaths, the coronary incidence has been increasing in women and decreasing in men. Contrary to belief, CAD causes far more deaths in women than does cancer (Figure 1). Consider the statistics: approximately 1 out of 3 women will die of a cardiovascular event; more than a half-million women die of CVD each year; one women dies of CVD almost each minute in the United States; and two-thirds of the women who die suddenly have no previously recognized symptoms. Advances in diagnosis and treatment of CVD appear to have translated into a survival benefit in men but not in women. The mortality due to CVD remains high in women, with no improvement in survival trends over time compared to men (Figure 2). This may be related to differences and delays in recognizing CVD in women or in treatment strategies, and to biological differences. Women with acute coronary syndrome often delay calling for professional help and present more frequently with atypical symptoms, such as abnormal pain locations, nausea, vomiting, fatigue, and dyspnea. Women not only present later from the onset of chest pain but are also sicker at the time of diagnosis. Furthermore, there appears to be a bias against heart disease in women - both patients and their caregivers/health care providers do not recognize or treat CVD in a timely manner in women. Compared to men, women are less likely to receive appropriate treatment for heart disease such as optimal control of blood pressure, use of aspirin, cholesterol-lowering medications, thrombolytics, or referrals for interventions such as balloon/ stent or bypass surgery. Women seem to be evaluated less intensively, and referrals for cardiac catheterization are 8-fold higher in men than in women. The clinical outcomes including myocardial infarction mortality, all-cause mortality, and reinfarction rates are worse in women with CVD than in men. Many risk factors contribute to CAD in women, but menopause is one of the strongest. Risk of CAD in postmenopausal women is 40 to 50% higher than in premenopausal women, and hormone replacement therapy (HRT) increases the risk. This paper discusses the myriad risk factors for CAD in women and explores the relationship between CAD and hormone replacement therapy in postmenopausal women.

The Relationship Between Sex Hormones and Extent of Coronary Artery Disease in Postmenopausal Women.

Associations between Coronary Heart Disease and Levels of Androgen and Inflammatory Factors in Elderly Man

Relationship Between Androgen Levels and Pathological Changes of Coronary Atherosclerosis in Elderly Males

A Study of the Relationships Between Serum Calcitonin Gene-Related Peptide, Sex Hormone, Homocysteine and Coronary Heart Disease in Postmenopausal Women.

Associations of proteins relevant to MAPK signaling pathway (p38MAPK-1,HIF-1 and HO-1) with coronary lesion characteristics and prognosis of peri-menopausal women

Association of bone metabolic markers with coronary artery disease and coronary arthrosclerosis in postmenopausal women

Characteristics of clinic and coronary lesion in premenopausal and postmenopausal women with coronary disease: a comparative analysis

Differences in Risk Factors for Coronary Atherosclerosis According to Sex

Where do we currently stand with advice on hormone replacement therapy for women?

Differences in Culprit Lesions Between Premenopausal and Postmenopausal Women with Acute Coronary Syndrome: an Optical Coherence Tomography Study

Relationship of Menopause with Cardiovascular Disease and Related Metabolic Disorders

Differences in coronary angiographic findings and outcomes between men and postmenopausal women with stable chest pain

Could remnant-like particle cholesterol become a risk factor in diabetic menopausal women with coronary artery disease? A cross-sectional study of single academic center in China

Abstract P3119: Identifying The Windows Of Cardiac Risk And Opportunity In Menopause

Sex differences in coronary atherosclerosis during the pre- and postmenopausal period—The Tampere sudden death study

Association between adiponectin and coronary artery disease in postmenopausal women

Study on the Characteristics of Traditional Chinese Medicine Syndrome and Coronary Angiography in Female with Coronary Heart Disease

Influence of Hypertension,Abnormal Lipid,Obesity to Coronary Heart Disease in Perimenopausal Women

Cardiometabolic Risk Factors and Endogenous Sex Hormones in Postmenopausal Women: A Cross-Sectional Study

Association of serum resistin levels with the severity of coronary artery lesions in postmenopausal women

Cardiovascular Fat, Menopause, and Sex Hormones in Women: The SWAN Cardiovascular Fat Ancillary Study